These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38575817)

  • 21. Pan-cancer genetic analysis of disulfidptosis-related gene set.
    Liu H; Tang T
    Cancer Genet; 2023 Nov; 278-279():91-103. PubMed ID: 37879141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disulfidptosis characterizes the tumor microenvironment and predicts immunotherapy sensitivity and prognosis in bladder cancer.
    Pan G; Xie H; Xia Y
    Heliyon; 2024 Feb; 10(3):e25573. PubMed ID: 38356551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Constructed Risk Prognosis Model Associated with Disulfidptosis lncRNAs in HCC.
    Jia X; Wang Y; Yang Y; Fu Y; Liu Y
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of disulfidptosis-related subtypes and development of a prognosis model based on stacking framework in renal clear cell carcinoma.
    Peng K; Wang N; Liu Q; Wang L; Duan X; Xie G; Li J; Ding D
    J Cancer Res Clin Oncol; 2023 Nov; 149(15):13793-13810. PubMed ID: 37530800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of disulfidptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in colorectal cancer.
    Li Y; Tang M; Dang W; Zhu S; Wang Y
    J Cancer Res Clin Oncol; 2023 Nov; 149(15):13995-14014. PubMed ID: 37543978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signature Construction and Disulfidptosis-Related Molecular Cluster Identification for Better Prediction of Prognosis in Glioma.
    Zhuang Y; Chen J; Mai Z; Huang W; Zhong W
    J Mol Neurosci; 2024 Apr; 74(2):38. PubMed ID: 38573391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of disulfidptosis-associated clusters on breast cancer survival rates and guiding personalized treatment.
    Chen X; Hu G; Yu Q
    Front Endocrinol (Lausanne); 2023; 14():1256132. PubMed ID: 38116315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of disulfidptosis-related genes and analysis of immune infiltration characteristics in ischemic strokes.
    Qin R; Huang L; Xu W; Qin Q; Liang X; Lai X; Huang X; Xie M; Chen L
    Math Biosci Eng; 2023 Oct; 20(10):18939-18959. PubMed ID: 38052584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction of a novel disulfidptosis-related signature for improving outcomes in hepatocellular carcinoma: Observational study.
    Chen X; Liang Q; Zhou Y
    Medicine (Baltimore); 2023 Oct; 102(40):e35423. PubMed ID: 37800779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigating the prognostic role of lncRNAs associated with disulfidptosis-related genes in clear cell renal cell carcinoma.
    Sun Z; Wang J; Fan Z; Yang Y; Meng X; Ma Z; Niu J; Guo R; Tran LJ; Zhang J; Jiang T; Liu Y; Yang Q; Ma B
    J Gene Med; 2024 Jan; 26(1):e3608. PubMed ID: 37897262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A disulfidptosis-related lncRNA prognostic model to predict survival and response to immunotherapy in lung adenocarcinoma.
    Zhang HB; Pan JY; Zhu T
    Front Pharmacol; 2023; 14():1254119. PubMed ID: 37822882
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification a unique disulfidptosis classification regarding prognosis and immune landscapes in thyroid carcinoma and providing therapeutic strategies.
    Feng Z; Zhao Q; Ding Y; Xu Y; Sun X; Chen Q; Zhang Y; Miao J; Zhu J
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11157-11170. PubMed ID: 37347261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel application of the ferroptosis-related genes risk model associated with disulfidptosis in hepatocellular carcinoma prognosis and immune infiltration.
    Wei J; Wang J; Chen X; Zhang L; Peng M
    PeerJ; 2024; 12():e16819. PubMed ID: 38317842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework.
    Zhao S; Wang L; Ding W; Ye B; Cheng C; Shao J; Liu J; Zhou H
    Front Endocrinol (Lausanne); 2023; 14():1180404. PubMed ID: 37152941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Creation of signatures and identification of molecular subtypes of glioblastoma based on disulfidptosis-related genes for predicting patient prognosis and immunological activity.
    Li D; Li X; Lv J; Li S
    Asian J Surg; 2024 Aug; 47(8):3464-3477. PubMed ID: 38462406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disulfidptosis-related signature predicts prognosis and characterizes the immune microenvironment in hepatocellular carcinoma.
    Tang J; Peng X; Xiao D; Liu S; Tao Y; Shu L
    Cancer Cell Int; 2024 Jan; 24(1):19. PubMed ID: 38195525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive Analysis of Disulfidptosis-Related LncRNAs in Molecular Classification, Immune Microenvironment Characterization and Prognosis of Gastric Cancer.
    Kang K; Li X; Peng Y; Zhou Y
    Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leveraging a gene signature associated with disulfidptosis identified by machine learning to forecast clinical outcomes, immunological heterogeneities, and potential therapeutic targets within lower-grade glioma.
    Zhou Y; Cao Y; Liu W; Wang L; Kuang Y; Zhou Y; Chen Q; Cheng Z; Huang H; Zhang W; Jiang X; Wang B; Ren C
    Front Immunol; 2023; 14():1294459. PubMed ID: 38162649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a disulfidptosis-related genes signature for prognostic implication in lung adenocarcinoma.
    Huang J; Zhang J; Zhang F; Lu S; Guo S; Shi R; Zhai Y; Gao Y; Tao X; Jin Z; You L; Wu J
    Comput Biol Med; 2023 Oct; 165():107402. PubMed ID: 37657358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and validation of disulfidptosis-associated molecular clusters in non-alcoholic fatty liver disease.
    Yu X; Guo Z; Fang Z; Yang K; Liu C; Dong Z; Liu C
    Front Genet; 2023; 14():1251999. PubMed ID: 37745847
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.